NVEC Form 4: Automatic 1,000-option grant to director on 08/07/2025
Rhea-AI Filing Summary
NVE Corporation director Wei Xuan Kelly was granted 1,000 non-qualified stock options automatically upon reelection to the board. The grant date and transaction date are 08/07/2025 with an exercise price of $61.72. The options are exercisable on 08/07/2025 and expire on 08/07/2035. Following the reported transaction, the filing shows 2,000 derivative securities beneficially owned (options) in total, with ownership reported as direct.
The disclosure was made on a Form 4 and signed by a power of attorney on 08/08/2025. The filing notes this was an automatic director award; no cash purchase or sale of underlying common stock is reported in this submission.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director compensation—an automatic option grant on reelection, aligning director incentives with shareholders.
The Form 4 documents a standard non-qualified stock option grant of 1,000 options to a director as an automatic element of board service. The exercise price of $61.72 and a 10-year term (08/07/2025–08/07/2035) are disclosed, and total derivative holdings increase to 2,000 options. This appears to be a governance-level compensation action rather than a signaling transaction by management. The filing contains no indication of accelerated vesting, cash payments, or related-party sales.
TL;DR: Disclosure is procedural and timely; no immediate liquidity or share issuance reported beyond option grant.
The Form 4 was filed to report the director's automatic option grant dated 08/07/2025 and was signed via power of attorney on 08/08/2025. The grant increases derivative holdings to 2,000 options, with the new tranche of 1,000 options exercisable immediately and carrying a $61.72 strike price. From an insider-trading perspective, there is no sale or exercise recorded here, so no immediate change to outstanding common shares is documented in this filing.